I am a biologist and researcher specializing in virology and antiviral drug development. I obtained my PhD in Genetics, Oncology and Clinical Medicine from the University of Siena in 2025, and I am currently attending the School of Specialization in Microbiology and Virology at the University of Pisa.
My research focuses on the identification and characterization of antiviral compounds, particularly against emerging and re-emerging RNA viruses, including flaviviruses and SARS-CoV-2. I am particularly interested in viral replication mechanisms, virus–host interactions, and cellular pathways involved in antiviral activity. I have experience in molecular biology, cell culture, and experimental virology, including working with BSL-2 and BSL-3 pathogens.
I have authored and co-authored several peer-reviewed scientific publications and presented my research at national and international conferences.
I am a biologist and researcher specializing in virology and antiviral drug development. I obtained my PhD in Genetics, Oncology and Clinical Medicine from the University of Siena in 2025, and I am currently attending the School of Specialization in Microbiology and Virology at the University of Pisa.
My research focuses on the identification and characterization of antiviral compounds, particularly against emerging and re-emerging RNA viruses, including flaviviruses and SARS-CoV-2. I am particularly interested in viral replication mechanisms, virus–host interactions, and cellular pathways involved in antiviral activity. I have experience in molecular biology, cell culture, and experimental virology, including working with BSL-2 and BSL-3 pathogens.
I have authored and co-authored several peer-reviewed scientific publications and presented my research at national and international conferences.